Neurologists Caution Against Weight-Loss Medications for ALS Patients
Neurologists are raising alarms about the potential dangers of popular weight-loss drugs, particularly for those suffering from neurodegenerative diseases like ALS (Amyotrophic Lateral Sclerosis). Dr. Jinsy Andrews, a neurologist at NYU Langone’s ALS Center, highlights that the rapid weight loss produced by these medications can be harmful to patients with neuromuscular disorders.
These medications, known as GLP-1 agonists, have been successful in managing obesity and diabetes, which affect many people. However, Dr. Andrews points out that the usual rules for these drugs shift when it comes to ALS patients.
While GLP-1 drugs are helpful in reducing inflammation and cardiovascular risks associated with obesity, they can negatively impact ALS patients. For individuals with ALS, weight loss can accelerate their decline, making it crucial to maintain or even gain weight to protect their nerves and muscles.
Standard medical advice for ALS patients typically encourages them to keep their weight stable or increase it to help maintain physical function. Losing weight due to these medications could worsen their condition, according to Dr. Andrews.
A notable case study published in the journal “Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration” examined a 52-year-old ALS patient who was prescribed the drug semaglutide for type 2 diabetes. After starting the medication, she lost 25 pounds over three months and saw a significant worsening of her symptoms. Once the drug was stopped, her condition stabilized.
Dr. Andrews emphasizes the growing evidence that healthcare professionals need to be cautious when prescribing GLP-1 medications for patients with ALS or similar diseases. While these treatments provide significant benefits for many, ensuring patients maintain their body weight and muscle mass is essential, especially for those with neurodegenerative disorders.
Ambre James-Brown, a spokesperson for Novo Nordisk, the manufacturer of Ozempic and Wegovy, reinforced the importance of patient safety but noted that ALS is not listed as an adverse reaction in their prescribing information.
In summary, while weight-loss medications may be effective for many, they can pose serious risks for ALS patients. Medical experts stress the need for careful consideration before prescribing these treatments to individuals with such underlying conditions.
